/UCW/ LOS ANGELES, CA – Care3™ (www.care3.co), the world’s first team collaboration platform for healthcare delivered in the home and community, announced the closing of its series seed round of financing. The round was led by J. Mario Molina, MD, former Chairman and CEO of Molina Healthcare, and current CEO of Golden Shore Medical, Inc. Dr. Molina is joined by Precursor Ventures and a group of blue chip angels who have the distinction of having served on the boards of groundbreaking technology companies including Netflix, Fitbit, LinkedIn, Skype and others.
“We are ecstatic to have our new investors join the Care3 family, especially Dr. Molina and Precursor Ventures,” says Care3 CEO & Co-Founder, David S. Williams. “Dr. Molina’s leadership and experience building care models for underserved populations via Managed Medicaid and Medicare Advantage is unparalleled. Precursor Ventures has already been a great partner growing Care3 to this stage and has the leadership to help us scale.”
Dr. Molina added, “The main focus of healthcare has shifted to keeping people out of hospitals. Care3 empowers care teams to engage families around care in the home and provides real-time alerts to enable interventions that can avoid emergency visits and hospitalizations. This is the future of community-based care.”
Care3 is currently working with multiple interdisciplinary care programs serving seniors, people with cancer, HIV and special needs children to improve collaboration and structured data collection in care planning, family engagement, and predictive analytics.
Care3™ is the world’s first team collaboration platform for healthcare delivered in the home and community. The HIPAA-compliant Care3 platform helps collaborative care programs (e.g. PACE) operate more effectively by driving visibility and accountability for care delivered outside of health facilities. This unprecedented insight enables care teams to intervene to prevent costly outcomes such as emergency visits and hospitalizations. Learn more at www.care3.co.